Drugs Used as Puberty Blockers for Gender Dysphoric Kids
Linked to Thousands of Deaths in Adults
by Jordyn Pair
September 26, 2019
DISRN
Drugs commonly used to as a treatment for gender dysphoria in gender-confused youth has been linked to thousands of death in adults, according to government data. The Food and Drug Administration says there have been thousands of death linked to Lupron, a puberty-blocking drug normally used to treat prostate cancer and endometriosis. Complications can include breast disorders, malignant neoplasmsa, and psychiatric and nervous disorders.
The FDA documented more than 40,500 adverse reactions to the drugs Lupron and triptorelin (which includes Lupron and similar drugs used by clinics) between 2012 and June 30 of this year. Over 25,500 reactions were labeled as “serious,” which included 6,370 deaths.
The drug can induce hypogonadotropic hypogonadism when injected into a normally-functioning body. “It’s a serious condition that endocrinologists would normally diagnose and treat because it interferes with development, but in [gender dysphoria] cases they’re inducing this disease state,” Michael Laidlaw, a Rocklin, California-based endocrinologist said in an interview with the National Catholic Register.
No comments:
Post a Comment